factual
Pharma Externalizing R&D to Biotechs and CROs
Since the 2000s big pharma has externalized most research to venture-funded biotechs and clinical trials to contract research organizations, leaving big pharma as commercialization machines whose remaining labs mainly validate external opportunities, and this could extend to commercial analysis and eventually to IP-holding shells.
factualpending
Speaker
AlexEvidence Quote
“So the big pharma companies are really just like commercialization machines all the time.”
Source
Alex Telford - Unlocking Innovation in Pharma - [Invest Like the Best, EP.360]— Invest Like the BestCreated: 11/14/2026, 6:42:06 AM
Your notes
Loading notes...